CORRECT: Amgen Anemia Drugs Are Aranesp, Epogen
(An item at 4:23 p.m. EST Friday incorrectly identified Amgen's anemia franchise.)
Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=7%2FK5XsmKTKlbfkvDKSg7eA%3D%3D. You can use this link on the day this article is published and the following day.
Publié le 19 Décembre 2008 Copyright © 2008 Dowjones
Partager sur:
Actualités
Suite »
- 04/11 : MARKET SNAPSHOT: U.S. Stocks Open Higher; Jobs Outlook… (DJ)
- 03/11 : Merck/Schering Cholesterol Drugs At Another Crossroads (DJ)
- 02/11 : FDA Says No To Application For Potential Lipitor/Zetia… (DJ)
- 29/10 : Priceline.com To Replace Schering-Plough In S&P 500… (DJ)
- 29/10 : UPDATE: US FTC Clears Merck-Schering Deal, With Conditions (DJ)
Actualités sectorielles
Suite »
- 06/11 : BOIRON : Déclaration des droits de vote (CN)
- 06/11 : VIRBAC : Déclaration d'actions et de droits de vote… (CN)
- 05/11 : Wall St Firms Shouldn't Get Scarce Flu Shots, Nonprofit… (DJ)
- 05/11 : Wendel: CA 9 mois -2,8% à EUR3,65 mds (DJ)
- 05/11 : Merckle To Narrow Bid List For Ratiopharm In Next… (DJ)